Abstract:
The present invention relates to a composition and kit for rheumatoid arthritis diagnosis or activity evaluation, the composition and kit each including an agent for measuring the concentration of at least one protein selected from a group consisting of soluble CD14 (sCD14), a-1-acid glycoprotein 1 (AGP1), and a-1-acid glycoprotein 2 (AGP2). Further, the present invention relates to a use of the composition for diagnosing rheumatoid arthritis or evaluating activity.
Abstract:
The present disclosure relates to: a method for preparing an animal in which the human immune system is expressed, by using human-induced pluripotent stem cells; and an animal prepared by the method.
Abstract:
The present invention relates to a composition for preventing or treating an autoimmune disease comprising, as an active ingredient, PINK1 protein or polynucleotide encoding the same. The PINK1 protein according to the present invention inhibits the activity of Th17, promotes the activity of a regulatory T cell (Treg), and increases autophagy in Treg cells, thereby controlling excessive immune responses. Therefore, the PINK1 protein can be effectively used as a pharmaceutical composition or an immunosuppressant, which is capable of preventing or treating an autoimmune disease, such as arthritis, and the like, caused by dysregulation of various kinds of immune responses.
Abstract:
The present invention relates to a use of mutant haptoglobin having angiogenesis-promoting activity and, more particularly, to a mutant haptoglobin polypeptide, a recombinant vector containing a polynucleotide encoding the polypeptide, or a composition for promoting angiogenesis containing, as an active ingredient, a transformant transformed with the recombinant vector. The mutant haptoglobin according to the present invention includes an amino acid sequence of SEQ ID NO: 1 in which the 143rd amino acid is substituted with an amino acid other than Arg. The mutant haptoglobin according to the present invention has excellent angiogenesis-promoting activity and excellent capillary-like tube formation capability as compared with wild-type haptoglobin, and promotes cell migration, and thus is useful as a therapeutic agent for treating diseases caused by non-angiogenesis.
Abstract translation:本发明涉及具有血管生成促进活性的突变型触珠蛋白的用途,更具体地说,涉及突变型触珠蛋白多肽,含有编码该多肽的多核苷酸的重组载体,或用于促进血管生成的组合物,其含有作为活性成分的 转化体用重组载体转化。 根据本发明的突变型触珠蛋白包含SEQ ID NO:1的氨基酸序列,其中第143位氨基酸被除Arg以外的氨基酸取代。 与野生型触珠蛋白相比,本发明的突变型触珠蛋白具有优异的血管生成促进活性和优异的毛细管样管形成能力,促进细胞迁移,因此可用作治疗由非 - 血管生成。
Abstract:
Provided are a composition for stimulating differentiation of MSCs into osteoblasts, which includes cryptotanshinone, and an osteogenesis stimulator including cryptotanshinone and MSCs. When the cryptotanshinone is treated to the MSCs, the differentiation into osteoblasts is stimulated, and thus osteogenesis of a patient may be stimulated by directly transplanting the differentiation-induced MSCs to the patient. Accordingly, the composition or osteogenesis stimulator may be used to treat patients having disability requiring stimulation of osteogenesis such as osteoporosis, bone fracture, bone grafting including alveolar bone grafting for implant placement, or other bone defects.
Abstract:
The present invention provides an anticancer adjuvant containing pentoxifylline. Pentoxifylline inhibits a collagen synthesis in tumors and consequently increases the distribution of an anticancer drug or sensitivity of cancer cells, which thus provides an improved anticancer treatment effect.
Abstract:
The present invention relates to a capsule endoscope for a photodynamic and sonodynamic therapy using magnetism. The capsule endoscope for a photodynamic and sonodynamic therapy using magnetism includes: an endoscope body; a light and ultrasonic wave irradiation part provided on an outer surface of the endoscope body, for irradiating light and ultrasonic waves having different wavelengths; and a photodynamic and sonodynamic therapy part connected to an outer surface of the endoscope body and including materials for a photodynamic and ultrasonic therapy, and the endoscope body has a positive electrode part and a negative electrode part having different polarities and is controlled such that the polarities are changed, and the photodynamic and sonodynamic therapy part is activated by photosensitizers leaked from a therapy part connected to the endoscope by light and ultrasonic waves irradiated by the light and ultrasonic wave irradiation part.
Abstract:
The present invention relates to an anterior capsulotomy guide device for cataract surgery. The present invention relates to an anterior capsulotomy guide device for cataract surgery which is temporarily inserted for anterior capsulotomy during cataract surgery, wherein the anterior capsulotomy guide device comprises a ring-shaped body, and a cut portion is formed by cutting a part of the body. According to the present invention, it is possible to carry out anterior capsulotomy with precise size and shape during cataract surgery, thereby maximizing the effect of cataract surgery.
Abstract:
The present invention relates to a capsule endoscope for photodynamic and sonodynamic therapy. The present invention comprises: an endoscope body; a light and ultrasonic wave irradiation portion provided on the outer surface of the endoscope body and irradiating light of different wavelengths and ultrasonic waves; and a photodynamic and sonodynamic therapy portion connected to the outer surface of the endoscope body and comprising a material for photodynamic and sonodynamic therapy, wherein the photodynamic and sonodynamic therapy portion can be activated by the light and ultrasonic waves irradiated from the light and ultrasonic wave irradiation portion. According to the present invention, the capsule endoscope can treat local bacterial infection, or diabetes, malignant diseases, chronic colitis and the like caused by a change in the number and type of intestinal floras while passing through the body in addition to carrying out diagnosis, which is the inherent function of a capsule endoscope, and thus there is no need for additional treatment and a patient can comfortably receive therapy.
Abstract:
The present invention relates to an apparatus for creating a tactile sensation through non-invasive brain stimulation by using ultrasonic waves. The apparatus includes: an ultrasonic transducer module for inputting the ultrasonic waves to stimulate a specific part of the brain of a specified user non-invasively through at least one ultrasonic transducer unit; a compensating module for acquiring information on a range of tactile perception areas in the brain of the specified user and compensating properties of ultrasonic waves to be inputted to the specified user through the ultrasonic transducer unit by referring to the acquired information thereon; and an ultrasonic waves generating module for generating ultrasonic waves to be inputted to the specified user through the ultrasonic transducer unit by referring to a compensating value decided by the compensating module.